author-photo

Jenny J. Kim

Johns Hopkins University

75

Papers

4124

Citations

Citation Trend

Filter By

Papers (57) Sort By

Journal Conference Others

Long-Term (≥4 Year and ≥5 Year) Overall Survival (OS) By 12- and 24-Month Event-Free Survival (EFS): An Updated Analysis of ZUMA-1, the Pivotal Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Refractory Large B-Cell Lymphoma (LBCL)

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Long-Term Survival and Gradual Recovery of B Cells in Patients (Pts) with Refractory Large B Cell Lymphoma (LBCL) Treated with Axicabtagene Ciloleucel (Axi-Cel)

2021
Show All
- Source
- Cite
- Save
Citations (1)
Prophylactic Corticosteroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Relapsed/Refractory Large B-Cell Lymphoma (R/R LBCL): One-Year Follow-up of ZUMA-1 Cohort 6 (C6)

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B-cell lymphoma.

2021 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (0)
Comparison of 2-year outcomes with CAR T cells (ZUMA-1) versus salvage chemotherapy in refractory large B-cell lymphoma.

2021 Blood Advances
Show All
- Source
- Cite
- Save
Citations (2)
Prophylactic Steroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Relapsed/Refractory Large B Cell Lymphoma (R/R LBCL)

2021
Show All
- Source
- Cite
- Save
Citations (6)
Prophylactic Steroid Use with Axicabtagene Ciloleucel in Patients with Relapsed/Refractory Large B-Cell Lymphoma

2021
Show All
- Source
- Cite
- Save
Citations (2)
Outcomes of Patients (Pts) in ZUMA-9, a Multicenter, Open-Label Study of Axicabtagene Ciloleucel (Axi-Cel) in Relapsed/Refractory Large B Cell Lymphoma (R/R LBCL) for Expanded Access (EA) and Commercial out-of-Specification (OOS) Product

2021
Show All
- Source
- Cite
- Save
Citations (0)
Prediction of Early Onset Cytokine Release Syndrome and Neurologic Events after Axicabtagene Ciloleucel in Large B-Cell Lymphoma Based on Machine Learning Algorithms

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B-cell lymphoma.

2021 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (3)